Latest News Archive
Please select Category, Year, and then Month to display items
11 June 2021
|
Story Rulanzen Martin
|
Photo Courtesy of artists and the Johannes Stegmann Gallery.
Liminality is an exhibition of first-, second- and third-year student’s work in the
Department of Fine Arts at the University of the Free State (UFS). The works are from 2019 and 2020. Created during the hard lockdown of 2020, the artworks provide a glimpse of what students had to deal with and overcome during these times.
In a proposal for the exhibition, Angela de Jesus, Curator of the UFS Art Galleries, wrote: “The subtitle of the exhibition is ‘threshold, transition, transformation’ and it refers to the creative processes that students engaged with
in these adverse circumstances resulting in a wide array of artworks in both traditional and adapted mediums.”
The exhibition speaks to our shared experiences of insecurity, fragility, and discord, and to the resourcefulness and immutability of creative expression.
The virtual exhibition runs until 2 July 2021.
The exhibition is also currently available for viewing at the Johannes Stegmann Art Gallery, Sasol Library, UFS Bloemfontein Campus. Monday - Friday 09:00 - 16:00.
MEGAN JOHNS, Battleground, Tobacco, charcoal dust, plaster of paris and resin, 93.5 x 50 x 7.5 cm
JACOBETH SELINGA, Linda, Installation: Found bed, wool and thread, 257 x 196 x 91 cm
POLOKO MOHANOE, Prayer for rain, Gouache on Fabriano, 66 x 72.8 cm
SEBOTSE SELAMULELA, In my image (Coronavirus head), Clay, 35 x 40 x 60 cm
WILLIAM SHAER, Creator, Deconstructed chair, koat wood and Imbura wood, 100 x 75 x 45 cm
Johannes Stegmann Gallery
Interior of the Johannes Stegmann Gallery
DNA sequencer launched at the UFS
2013-11-25
 |
Dr Gansen Pillay, Deputy Chief Executive Officer of the National Research Foundation, explaining to the scholars what will be expected of them. |
The University of the Free State (UFS) can now collect immensely valuable data on drug resistance in HIV/Aids and TB with the new DNA sequencer that was launched recently at the International workshop on HIV/AIDS and TB drug resistance at the Bloemfontein Campus.
The DNA sequencer will allow the Free State province to produce viral and bacterial genetic data to fight the local development of HIV/ Aids and TB drug resistance.
The HIV and TB epidemics have expanded very fast and South Africa now has the largest HIV and TB treatment programme in the world, with over 2 million patients on treatment. However, these successful treatment programmes are now being threatened by the appearance of drug resistance.
The Free State province has been at the forefront of fighting HIV drug resistance in South Africa and has one of the most advanced treatment programmes for the management of resistance strains in the country. In addition, researchers at the University of the Free State are leading partners in the Southern African Treatment and Resistance Network (SATuRN; www.bioafrica.net/saturn), a research network that has trained over 2 000 medical officers in the treatment of drug resistance strains.
The Department of Medical Microbiology and Virology in the Medical School at the UFS has partnered with the provincial department of health, the Medical Research Council (MRC) and the Delegation of the European Union to South Africa to fund a dedicated DNA sequencer machine that will be used to generate HIV and TB drug-resistance results. This new machine will enable cutting-edge research to take place, using the data in the province and, importantly, support patients with resistance strains to have access to advanced genotypic testing techniques.
“HIV drug resistance is a very serious problem in South Africa, and the recent advances in DNA testing technology allow clinicians in the province to access drug resistance testing, which enables them to manage patients appropriately who fail treatment, and use the results to cost-effectively extend and improve patients’ lives,” says Dr Cloete van Vuuren, Specialist in Infectious Diseases at the UFS’s Faculty of Health.
Dr Dominique Goedhals, pathologist from the Department of Medical Microbiology and Virology at the UFS, adds: “We have been looking forward to expanding our work with the clinicians and researchers, using DNA sequencing to shed light on the causes and consequences of drug resistance in urban and rural settings in the province.”